Zacks Research Has Bullish Outlook for MKS FY2026 Earnings

MKS Inc. (NASDAQ:MKSI) – Investment analysts at Zacks Research lifted their FY2026 earnings per share estimates for MKS in a research report issued to clients and investors on Tuesday, March 10th. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will post earnings of $8.76 per share for the year, up from their previous forecast of $7.16. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for MKS’s current full-year earnings is $6.94 per share. Zacks Research also issued estimates for MKS’s Q4 2026 earnings at $2.42 EPS.

A number of other analysts have also recently commented on MKSI. Bank of America upped their price target on shares of MKS from $215.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, January 22nd. Mizuho set a $320.00 price objective on shares of MKS in a research note on Thursday, February 19th. Morgan Stanley reissued an “overweight” rating and set a $300.00 target price on shares of MKS in a report on Thursday, February 19th. JPMorgan Chase & Co. increased their target price on MKS from $265.00 to $305.00 and gave the stock an “overweight” rating in a research report on Thursday, February 19th. Finally, Citigroup lifted their price target on MKS from $185.00 to $295.00 and gave the company a “buy” rating in a research report on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $273.46.

MKS Price Performance

Shares of NASDAQ:MKSI opened at $213.49 on Thursday. The firm has a market capitalization of $14.36 billion, a PE ratio of 48.85, a P/E/G ratio of 1.20 and a beta of 1.94. The company has a quick ratio of 1.71, a current ratio of 2.71 and a debt-to-equity ratio of 1.53. The company has a 50-day moving average price of $225.73 and a two-hundred day moving average price of $169.03. MKS has a twelve month low of $54.84 and a twelve month high of $269.91.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 earnings per share for the quarter, missing the consensus estimate of $2.51 by ($0.04). The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.02 billion. MKS had a return on equity of 20.85% and a net margin of 7.53%.The firm’s revenue was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.15 EPS. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS.

Institutional Trading of MKS

Several institutional investors have recently added to or reduced their stakes in the business. Covestor Ltd grew its position in MKS by 14.7% during the 4th quarter. Covestor Ltd now owns 390 shares of the scientific and technical instruments company’s stock worth $63,000 after acquiring an additional 50 shares during the last quarter. Daiwa Securities Group Inc. boosted its stake in shares of MKS by 10.4% during the fourth quarter. Daiwa Securities Group Inc. now owns 530 shares of the scientific and technical instruments company’s stock valued at $85,000 after purchasing an additional 50 shares during the period. Quadrant Capital Group LLC boosted its stake in shares of MKS by 1.3% during the fourth quarter. Quadrant Capital Group LLC now owns 4,335 shares of the scientific and technical instruments company’s stock valued at $693,000 after purchasing an additional 55 shares during the period. MassMutual Private Wealth & Trust FSB grew its holdings in shares of MKS by 6.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 898 shares of the scientific and technical instruments company’s stock worth $144,000 after purchasing an additional 58 shares during the last quarter. Finally, Northwestern Mutual Investment Management Company LLC increased its stake in shares of MKS by 0.4% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 15,028 shares of the scientific and technical instruments company’s stock worth $2,401,000 after buying an additional 58 shares during the period. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO John Tseng-Chung Lee sold 30,000 shares of MKS stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $256.77, for a total transaction of $7,703,100.00. Following the completion of the sale, the chief executive officer owned 154,696 shares in the company, valued at approximately $39,721,291.92. This trade represents a 16.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Elizabeth Mora sold 300 shares of MKS stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $239.44, for a total transaction of $71,832.00. Following the sale, the director owned 18,663 shares of the company’s stock, valued at approximately $4,468,668.72. The trade was a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 68,163 shares of company stock valued at $17,215,417 in the last ninety days. 0.57% of the stock is owned by insiders.

MKS Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Monday, February 23rd were issued a $0.25 dividend. The ex-dividend date of this dividend was Monday, February 23rd. This is an increase from MKS’s previous quarterly dividend of $0.22. This represents a $1.00 annualized dividend and a dividend yield of 0.5%. MKS’s payout ratio is currently 22.88%.

Key Headlines Impacting MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: MKS announced that its near‑term science‑based emissions reduction targets were approved by the Science Based Targets initiative (SBTi), a credibility boost for the company’s ESG profile that can broaden investor interest. MKS Inc. Announces SBTi Approval of Science-Based Emissions Reduction Targets
• Positive Sentiment: Research firm Zacks issued a string of upward revisions and maintains a “Strong‑Buy” stance — raising near‑term and multi‑year EPS forecasts (multiple quarters, FY2026–FY2028). Those estimate lifts support a continued growth narrative and may underpin longer‑term upside.
• Positive Sentiment: Market commentary highlights accelerating end‑market demand tied to AI and a photonics product launch as drivers for recent share‑price gains; analysts and investors have been re‑rating the stock on that secular exposure. Assessing MKS Instruments (MKSI) Valuation After AI Demand And Photonics Launch Fuel Strong Share Price Gains
• Positive Sentiment: Investor letters and market notes point to improving end markets contributing to MKS’s momentum, reinforcing demand recovery themes that support revenue and margin outlooks. MKS (MKSI) Gained from End Markets Picking Up
• Neutral Sentiment: Amid many upward revisions, Zacks made a small downward tweak to one quarter (Q2 2027) — a minor calibration versus the broader set of raises; overall Zacks remains bullish.
• Negative Sentiment: Despite the positive newsflow, the stock is pulling back — most likely due to profit‑taking after a strong run (valuation is rich: trailing P/E ~48.9) and lingering sensitivity to quarterly beats/misses. The company slightly missed the most recent quarterly EPS consensus by $0.04, which can amplify short‑term volatility and sell‑side caution.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.